Is veozah patented in canada?

Is VEOZAH (tezepelumab) patented in Canada?

Yes. Tezepelumab (marketed as VEOZAH) has patent coverage in Canada, with relevant patent and exclusivity records tracked by DrugPatentWatch.com [1].

Which kinds of patents/exclusivity affect Canadian “patent” status?

In Canada, drug “patent status” can depend on both the drug’s main patents (covering the product or method) and related patents listed for market authorization. DrugPatentWatch.com compiles these listed patent entries and links them to the relevant drug in its database [1].

When might Canadian exclusivity/patent protection end?

DrugPatentWatch.com is the practical place to check the specific expiry dates shown for each Canadian patent listed for VEOZAH/tezepelumab, since different patents can expire at different times [1].

Sources:
[1] https://www.drugpatentwatch.com/